PIK-C98 is a PI3K inhibitor. It acts by displaying potent preclinical activity against multiple myeloma. References: Zhu J, Wang M, Yu Y, Qi H, Han K, Tang J, Zhang Z, Zeng Y, Cao B, Qiao C, Zhang H, Hou T, Mao X. A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma. Oncotarget. 2015 Jan 1;6(1):185-95. PubMed PMID: 25474140; PubMed Central PMCID: PMC4381587.

纯度：≥98%

CAS：691388-62-2